Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF
- PMID: 23770519
- DOI: 10.1161/CIRCHEARTFAILURE.112.000265
Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF
Abstract
Background: Hospital readmission is an important clinical outcome of patients with heart failure. Its relation to length of stay for the initial hospitalization is not clear.
Methods and results: We used hierarchical modeling of data from a clinical trial to examine variations in length of stay across countries and across hospitals in the United States and its association with readmission within 30 days of randomization. Main outcomes included associations between country-level length of stay and readmission rates, after adjustment for patient-level case mix; and associations between length of stay and readmission rates across sites in the United States. Across 27 countries with 389 sites and 6848 patients, mean length of stay ranged from 4.9 to 14.6 days (6.1 days in the United States). Rates of all-cause readmission ranged from 2.5% to 25.0% (17.8% in the United States). There was an inverse correlation between country-level mean length of stay and readmission (r=-0.52; P<0.01). After multivariable adjustment, each additional inpatient day across countries was associated with significantly lower risk of all-cause readmission (odds ratio, 0.86; 95% confidence interval, 0.75-0.98; P=0.02) and heart failure readmission (odds ratio, 0.79; 95% confidence interval, 0.69-0.99; P=0.03). Similar trends were observed across US study sites concerning readmission for any cause (odds ratio, 0.92; 95% confidence interval, 0.85-1.00; P=0.06) and readmission for heart failure (odds ratio, 0.90; 95% confidence interval, 0.80-1.01; P=0.07). Across countries and across US sites, longer median length of stay was independently associated with lower risk of readmission.
Conclusions: Countries with longer length of stay for heart failure hospitalizations had significantly lower rates of readmission within 30 days of randomization. These findings may have implications for developing strategies to prevent readmission, defining quality measures, and designing clinical trials in acute heart failure.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00475852.
Keywords: heart failure; hospitalization; length of stay; outcome research; patient readmission.
Similar articles
-
Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days.Am Heart J. 2013 Jun;165(6):987-994.e1. doi: 10.1016/j.ahj.2013.02.006. Epub 2013 Apr 6. Am Heart J. 2013. PMID: 23708171
-
Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.Eur J Heart Fail. 2015 Oct;17(10):1022-31. doi: 10.1002/ejhf.282. Epub 2015 May 9. Eur J Heart Fail. 2015. PMID: 25960401
-
Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients.Acad Emerg Med. 2013 Jun;20(6):554-61. doi: 10.1111/acem.12147. Acad Emerg Med. 2013. PMID: 23758301
-
The Burden of Rehospitalization for Patients With Liver Cirrhosis.Hosp Pract (1995). 2016;44(1):60-9. doi: 10.1080/21548331.2016.1142828. Epub 2016 Feb 3. Hosp Pract (1995). 2016. PMID: 26782133 Review.
-
An integrative review of the literature on in-hospital worsening heart failure.Heart Lung. 2018 Sep-Oct;47(5):437-445. doi: 10.1016/j.hrtlng.2018.06.005. Epub 2018 Jul 3. Heart Lung. 2018. PMID: 29980304 Review.
Cited by
-
Associations Between Hospital Length of Stay, 30-Day Readmission, and Costs in ST-Segment-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis.J Am Heart Assoc. 2020 Jun 2;9(11):e015503. doi: 10.1161/JAHA.119.015503. Epub 2020 May 29. J Am Heart Assoc. 2020. PMID: 32468933 Free PMC article.
-
Hospital readmission in heart failure, a novel analysis of a longstanding problem.Heart Fail Rev. 2015 May;20(3):251-8. doi: 10.1007/s10741-014-9459-2. Heart Fail Rev. 2015. PMID: 25287658 Review.
-
Hospital length of stay and all-cause 30-day readmissions among high-risk Medicaid beneficiaries.J Hosp Med. 2016 Apr;11(4):283-8. doi: 10.1002/jhm.2526. Epub 2015 Dec 15. J Hosp Med. 2016. PMID: 26669942 Free PMC article.
-
Predictors of Rehospitalization Among Adults With Congenital Heart Disease Are Lesion Specific.Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):566-75. doi: 10.1161/CIRCOUTCOMES.116.002733. Epub 2016 Sep 13. Circ Cardiovasc Qual Outcomes. 2016. PMID: 27625407 Free PMC article.
-
Thoracentesis to alleviate pleural effusion in acute heart failure: study protocol for the multicentre, open-label, randomised controlled TAP-IT trial.BMJ Open. 2024 Jan 19;14(1):e078155. doi: 10.1136/bmjopen-2023-078155. BMJ Open. 2024. PMID: 38245015 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous